已签订超60亿美元合作交易。本文为IPO早知道原创作者|Stone Jin微信公众号|ipozaozhidao据IPO早知道消息,Duality Biotherapeutics, Inc.(以下简称“映恩生物”)今日(4月7日)开启招股、至10日结束,并计划于2025年4月15日正式以“9606”为股票代码在港交所主板挂牌上市。映恩生物计划在本次IPO中发行15,071,600股股份。其中,香港...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.